Listen To Voters President Obama, Not The Vice President!
According to Rolling Stone: “There are not many friends to legalization in this administration,” says Kevin Sabet, director of the Drug Policy Institute at the University of Florida who served the White House as a top adviser on marijuana policy. In fact, the politician who coined the term “drug czar” – Joe Biden – continues to guide the administration’s hard-line drug policy. “The vice president has a special interest in this issue,” Sabet says. “As long as he is vice president, we’re very far off from legalization being a reality.”
We’ve got a decidedly baby boom president and former leader of the Choom Gang as the so-called elected leader of the free world, but reform of cannabis prohibition is supposedly being held up by the World War II era-influenced, and current self-described “drug warrior” Joe Biden?
Let’s send a clear message to President Obama to sensibly pay attention to public polls and election vote totals regarding the tenor of America quickly moving away from the failed eight decade-old federal cannabis prohibition and embracing logical public policy alternatives–notably taxing and regulating cannabis products in a manner similar to alcohol and tobacco products–and NOT to his stodgy, longtime prohibitionist and disconnected Vice President.**
Please sign this White House petition here.
**Joe Biden, when he was a Senator from Delaware, led the Democrats’ efforts in the 1980s to try to rebuff longtime and successful Republican efforts to paint Democrats as ‘being soft on crime and weak on drugs’ by helping to create the Office of National Drug Control Policy (AKA Drug Czar’s office) and inserting into its mission statement one of the most anti-democratic and anti-free market charters of all time in a government bureaucracy.
According to Title VII Office of National Drug Control Policy Reauthorization Act of 1998: H11225:
Responsibilities. –The Director– […]
(12) shall ensure that no Federal funds appropriated to the Office of National Drug Control Policy shall be expended for any study or contract relating to the legalization (for a medical use or any other use) of a substance listed in schedule I of section 202 of the Controlled Substances Act (21 U.S.C. 812) and take such actions as necessary to oppose any attempt to legalize the use of a substance (in any form) that–
is listed in schedule I of section 202 of the Controlled Substances Act (21 U.S.C. 812); and
has not been approved for use for medical purposes by the Food and Drug Administration;
December 12, 2012